Skip to content

CG Oncology CGON Earnings yield

Earnings yield at other companies

Pfizer logo
PfizerPFE
6.8%
Johnson & Johnson logo
Johnson & JohnsonJNJ
3.6%-1.9pp
Gilead Sciences logo
Gilead SciencesGILD
5.3%+1.1pp
ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX
-10.8%-2.6pp
Cogent Biosciences, Inc. logo
Cogent Biosciences, Inc.COGT
-5.7%-2.6pp
Tango Therapeutics logo
Tango TherapeuticsTNGX
-3.6%-1.8pp

Other financials

Income statement

See full
Revenue$1.1M+1,983%
Operating income-$66.4M-57.3%
Net income-$60.2M-74.7%
EPS (diluted)-$0.71-57.8%

Balance sheet

See full
Cash & equivalents$33.7M-18.7%
Total debt$7.6M+631%
Total equity$1.1B+54.9%
Total assets$1.1B+55.9%

Cash flow

See full
Operating cash flow-$56.9M-94.5%
CapEx$304.0K+1,800%
Free cash flow-$57.2M-95.4%

Valuation

See full
Market cap$5.39B+206%
Enterprise value$5.36B+212%
P/S1,062.4×-1,596×

Profitability

See full
Operating margin-4,239%-1,872pp
Net margin-3,682.6%-1,601pp
FCF margin-3,163.8%-1,351pp

Returns & leverage

See full
Return on equity-20.8%+7.1pp
Debt / equity0.0×
Current ratio31.3×+0.3×

Where this comes from

Calculated from CG Oncology’s reported figures.

Based on trailing twelve months.

The official record: CG Oncology’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about CG Oncology's earnings yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CG Oncology's earnings yield?
CG Oncology (CGON) reported earnings yield of -3.3% in Q1 2026.
How has CG Oncology's earnings yield changed year-over-year?
CG Oncology's earnings yield increased by 42.2% year-over-year, from -5.7% to -3.3%.
What does earnings yield mean?
Trailing-twelve-month net income divided by market capitalization at the quarter end — the inverse of the P/E ratio, expressed as a percentage.